J&J’s Risperdal makes the news again.

Arkansas judge fined the company and a subsidiary more than $1.1 billion for downplaying and concealing risks associated with the antipsychotic drug Risperdal
http://www.huffingtonpost.com/huff-wires/20120411/us-antipsychotic-drug-trial/

http://www.pharmalot.com/2012/04/jj-is-fined-1-billion-over-risperdal-marketing/

Be Sociable, Share!
You can leave a response, or trackback from your own site.

Leave a Reply


Design by Aaron Melvin